Navigation Links
Graphene: What can go wrong? new studies point to wrinkles, process contaminants
Date:7/7/2011

Using a combination of sophisticated computer modeling and advanced materials analysis techniques at synchrotron laboratories, a research team led by the University at Buffalo (UB) and including the National Institute of Standards and Technology (NIST), the Molecular Foundry at Lawrence Berkeley National Laboratory and SEMATECH* has demonstrated how some relatively simple processing flaws can seriously degrade the otherwise near-magical electronic properties of graphene.

Their new paper** demonstrates how both wrinkles in the graphene sheet and/or chance contaminants from processingpossibly hiding in those foldsdisrupt and slow electron flow across the sheet. The results could be important for the design of commercial manufacturing processes that exploit the unique electrical properties of graphene. In the case of contaminant molecules at least, the paper also suggests that heating the graphene may be a simple solution.

Graphene, a nanostructured material that is essentially a one-atom thick sheet of carbon atoms arranged in a hexagonal pattern, is under intense study because of a combination of outstanding properties. It's extremely strong, conducts heat very well, and has high electrical conductivity while being flexible and transparent. Graphene's electrical properties, however, apparently depend a lot on flatness and purity.

Using X-rays, the UB team produced images that show the electron "cloud" lining the surface of graphene samplesthe structure responsible for the high-speed transit of electrons across the sheetand how wrinkles in the sheet distort the cloud and create bottlenecks. Spectrographic data showed anomalous "peaks" in some regions that also corresponded to distortions of the cloud. NIST researchers, using their dedicated materials science "beam line" at the National Synchrotron Light Source (NSLS),*** contributed a sensitive analysis of spectroscopic data confirming that these peaks were caused by chemical contaminants that adhered to the graphene during processing.

Significantly, the NIST synchrotron methods group was able to make detailed spectroscopic measurements of the graphene samples while heating them, and found that the mysterious peaks disappeared by the time the sample reached 150 degrees Celsius. This, according to Dan Fischer, leader of the NIST group, showed both that those particular disturbances in the electron cloud were due to contaminants, and that there is a way to get rid of them. "They're not chemical bound, they're just physically absorbed on the surface, and that's an important thing. You have a prescription for getting rid of them," Fischer said.

"When graphene was discovered, people were just so excited that it was such a good material that people really wanted to go with it and run as fast as possible," said Brian Schultz, one of three UB graduate students who were lead authors on the paper, "but what we're showing is that you really have to do some fundamental research before you understand how to process it and how to get it into electronics."

"This is the practical side of using graphene," agrees Fischer, "It has all these remarkable properties, but when you go to actually try to make something, maybe they stop working, and the question is: why and what do you do about it? These kinds of extremely sensitive, specialized techniques are part of that answer."


'/>"/>

Contact: Michael Baum
baum@nist.gov
301-975-2763
National Institute of Standards and Technology (NIST)
Source:Eurekalert

Related biology technology :

1. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
2. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
3. Otonomys OTO-104 Demonstrates Hearing Loss Protection and Hearing Recovery in Preclinical Studies
4. Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
5. Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx® in Cancer Treatment Options
6. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
7. Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy
8. Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology
9. Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program
10. Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
11. Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... In anticipation of ... lumbar disc production, company President, Jake Lubinski will be traveling to Germany on ... disc in Cologne and Karlsruhe to discuss the benefits of a viscoelastic total ...
(Date:12/5/2016)... WOODCLIFF LAKE, N.J. , Dec. 5, 2016 ... its Phase 3 open-label two-year study of rufinamide, ... of the American Epilepsy Society (AES) held from ... . Analysis of final two-year safety, tolerability and ... therapy with rufinamide experienced similar safety and tolerability ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016  In five ... of Hematology (ASH) Annual Meeting and Exposition in ... biomedical engineering methods to improve the delivery of life-saving ... These new methods are designed to carry therapies directly ... needed most, which could provide a substantial advantage over ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
Breaking Biology Technology:
(Date:11/17/2016)... , Nov. 17, 2016  AIC announces that it has just released a new ... that require high-performance scale-out plus high speed data transfer storage solutions. Photo ... ... ... Setting up a high performance computing ...
(Date:11/15/2016)... Nov 15, 2016 Research and Markets has ... to 2021" report to their offering. ... ... Billion by 2021 from USD 6.21 Billion in 2016, growing at ... Growth of the bioinformatics market is driven by the growing demand ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
Breaking Biology News(10 mins):